IRCT20170112031891N2
Completed
Phase 3
Investigating the effectiveness of L-arginine in reducing duration of hospitalization and pain intensity of children with sickle cell disease compared to placebo.
Overview
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 120
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 3 years to 20 years (—)
- Sex
- All
Inclusion Criteria
- •Patients affected by sickle cell disease
- •Age 3 to 20 years
Exclusion Criteria
- •liver failure
- •Renal failure
- •Under 5 grams of hemoglobin per deciliter
- •Patients in need of immediate infusion of blood
- •History of hospitalization more than 10 times in the hospital
- •A history of opiate dependence
- •Sensitivity to arginine
Investigators
Similar Trials
Not yet recruiting
Not Applicable
recording efficacy of l-arginine in improving outcomes in patients with oligohydramniosHealth Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperiumCTRI/2024/04/065276none
Completed
Phase 3
Investigation of the effect of oral L-arginine on pulmonary hypertension in patients with thalassemia majorIRCT20191218045785N1Shahre-kord University of Medical Sciences50
Not yet recruiting
Phase 3
The effect of L-arginine in non-alcoholic fatty liverIRCT20230409057859N1Shahid Beheshti University of Medical Sciences60
Recruiting
Phase 3
Comparison between L-arginine and aspirin and aspirin alone in preventing preeclampsia in high-risk pregnant women.IRCT20221108056440N1Kashan University of Medical Sciences90
Completed
Not Applicable
The effect of L- arginine supplementation on metabolic syndrome.Metabolic Syndrome.-IRCT2015120425245N2for research of Yazd Shahid Sadoughi University of Medical Sciences60